This setting lets you change the way you view articles. You can choose to have articles open in a dialog window, a new tab, or directly in the same window.
Open in Dialog
Open in New Tab
Open in same window
Open in New Tab
Open in same window

American Economic Journal: Applied Economics: Vol. 4 No. 3 (July 2012)
AEJ: Applied Volume. 4, Issue 3 |
Previous ArticleNext Article
Sign up for Email Alerts Follow us on Twitter Subscription Information
(Institutional Administrator Access)
AEJ: Applied Forthcoming Articles
Full-text Article
Download Data Set (891.06 KB)
View Comments on This Article (0) | Login to post a comment
Previous ArticleNext Article
Expand
Quick Tools:
Print Article Summary Email Link to this Article Export CitationSign up for Email Alerts Follow us on Twitter Subscription Information
(Institutional Administrator Access)
Explore:
AEJ: Applied Forthcoming Articles
The Economic Benefits of Pharmaceutical Innovations: The Case of Cox-2 Inhibitors
Article Citation
Garthwaite, Craig L. 2012. "The Economic Benefits of Pharmaceutical Innovations: The Case of Cox-2 Inhibitors."
American Economic Journal: Applied Economics,
4(3): 116-37.
DOI: 10.1257/app.4.3.116
DOI: 10.1257/app.4.3.116
Abstract
Despite dramatic improvements in medical technology, little attention
has been paid to the role of these innovations in improving economic outcomes. This study estimates the labor supply effects of Cox-2 inhibitors, a widely prescribed class of pharmaceuticals used for the treatment of chronic pain and inflammation and primarily marketed under the brand names Vioxx, Celebrex, and Bextra. This paper exploits the removal of Vioxx from the market in 2004 as an exogenous change in drug use. This removal was associated with a
0.35 percentage point decrease in overall labor force participation and $19 billion in lost wages. (JEL I12, J22, L65, O31).
Article Full-Text Access
Full-text Article
Additional Materials
Download Data Set (891.06 KB)
Authors
Garthwaite, Craig L. (Northwestern U)
JEL Classifications
I12: Health Production
J22: Time Allocation and Labor Supply
L65: Chemicals; Rubber; Drugs; Biotechnology
O31: Innovation and Invention: Processes and Incentives
J22: Time Allocation and Labor Supply
L65: Chemicals; Rubber; Drugs; Biotechnology
O31: Innovation and Invention: Processes and Incentives
Comments
View Comments on This Article (0) | Login to post a comment

